Stainless Steel in Pharmaceutical Manufacturing: 316L vs. 317L vs. 6Mo

 

Why is 316L the baseline for pharmaceutical equipment?
316L provides excellent corrosion resistance to cleaning agents and process chemicals while being easy to sanitize. Its low carbon content prevents carbide precipitation during welding, maintaining corrosion resistance at heat-affected zones. The smooth surfaces required in pharma applications are easily achieved with 316L

 

When is 317L specified for pharmaceutical use?
317L is used when higher molybdenum content (3-4%) is needed for enhanced resistance to chlorides and acids. It's common in API production where aggressive chemical environments are encountered. The extra alloying elements provide better pitting resistance in high-chloride cleaning solutions.

 

What are the advantages of 6Mo super austenitic steels in pharma?
6Mo grades (like AL-6XN) offer exceptional resistance to harsh sterilants and acidic solutions. Their high PREN (>40) prevents crevice corrosion in gasketed joints and threaded connections. These alloys are used for critical components in biopharma processing where product purity is paramount.

 

How important is surface finish in pharmaceutical stainless steel?
Electropolished surfaces with Ra <0.5 μm are standard to prevent microbial adhesion and allow thorough cleaning. Passivation after fabrication ensures optimal corrosion resistance. Mirror finishes are required for some sterile processing applications to facilitate visual inspection

 

What validation requirements apply to pharma-grade stainless?
Materials must be traceable with certified composition and mechanical properties. Surface roughness must be documented and verified. Welding procedures require qualification, and all welds must be inspected. Regular material verification ensures ongoing compliance with FDA and EMA requirements.